MP82-10 PREDICTIVE MODEL FOR SYSTEMIC RECURRENCE FOLLOWING CISPLATIN-BASED NEOADJUVANT CHEMOTHERAPY AND RADICAL NEPHROURETERECTOMY FOR UPPER TRACT UROTHELIAL CARCINOMA

INTRODUCTION AND OBJECTIVE:Based on the established benefit of neoadjuvant chemotherapy (NAC) in urothelial cancer of the bladder, NAC is increasingly used prior to radical nephroureterectomy (RNU)...